Physician
Pathology
Dr. Thomas S. Lorey, MD
|
|
Give Review
Doctor Thomas S. Lorey, MD works in the field of Pathology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical university. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care Dr. Thomas S. Lorey is a published MD. He published 46 publications, including: 'An unusual cause for severe dyspnea and sudden death in a young man.' Thomas Lorey is registered with Medicare and accepts Medicare payments.
Publications
- Age, sex, and racial influences on the Beckman Coulter AccuTnI+3 99th percentile.
- Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
- Challenges in harmonizing integrated healthcare network laboratories: Multi-center evaluation of the AccuTnI+3 troponin assay.
- Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.
- The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications ...
- Falsely Undetectable TSH in a Cohort of South Asian Euthyroid Patients.
- Neonatal total bilirubin measurements: Still room for harmonization.
- Development of an equation to correct for hemolysis in direct bilirubin measurements.
- Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap.
- Identification of One or Two α-Globin Gene Deletions by Isoelectric Focusing Electrophoresis.
- Performance specifications of common chemistry analytes on the AU series of chemistry analyzers for miscellaneous body fluids.
- Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men.
- Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettage.
- Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management.
- Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less.
- Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results.
- Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results.
- Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results.
- Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines.
- A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: Evidence against retesting.
- Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.
- A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.
- Limitations in qualitative point of care hCG tests for detecting early pregnancy.
- HPV genotyping, HPV mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected men who have sex with men.
- Screening history preceding a diagnosis of cervical cancer in women age 65 and older.
- Interrater agreement of anal cytology.
- Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies.
- Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
- Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
- Variable risk of cervical precancer and cancer after a human papillomavirus-positive test.
- Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice.
- Risk of cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening result.
- The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
- Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.
- Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.
- Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.
- Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
- Hemangiosarcoma after endovascular aortic aneurysm repair.
- Cerebral vein thrombosis associated with aneurysmal subarachnoid bleeding: implications for treatment.
- Endothelin-induced contraction of the portal vein in cirrhosis.
- An unusual cause for severe dyspnea and sudden death in a young man.
- [In vitro contractility behavior of portal veins in normal rats and in rats with liver cirrhosis--effect of calcium antagonists and octreotide].
Schools
University Of Ca School Of Med
Kaiser Permanente Med Center Sf
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
Kaiser Permanente Medical Center -
University of California San Diego -
University of California San Francisco School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235289059 |
| Last Name Of The Provider | LOREY |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. James McCole, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Compagno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah B. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johanna Reneke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gene F. Pawlick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane A. Tokugawa, MD
This Doctor is OpenDoctor Recommended.
|